Kishore M. Gadde - Concepedia

Author

Kishore M. Gadde

Also Known As

Gadde, K.M., George A. Bray, K M Gadde, K. Gadde, K. M. Gadde, K.M. Gadde, KISHORE GADDE, KISHORE M. GADDE, Karan Uppal, Kishore Gadde

133

Publications

8.9K

Citations

H-Index

Concepts

All Affiliations

Duke University Duke Medical Center Pennington Biomedical Research Center Duke University Hospital National Institute of Diabetes and Digestive and Kidney Diseases

About

Kishore M. Gadde is an author at Duke University specializing in medicine, obesity, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	3.3K
2	Health Sciences	6	6	1.9K
3	Social Sciences	4	4	117
4	Public Health	3	3	63
5	Applied Physiology	2	2	77

Kishore M. Gadde

Publications

Citations

H-Index

Page 1

	Year	Citations
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial Kishore M. Gadde, David B. Allison, Donna H. Ryan, The Lancet ObesityHealth PolicyTopiramate CombinationAssociated ComorbiditiesObesity Management	2011	1K
Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) David B. Allison, Kishore M. Gadde, W. Timothy Garvey, Obesity NutritionBariatric SurgeryClass IiSeverely Obese AdultsCardiometabolic Risk	2011	703
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study W. Timothy Garvey, Donna H. Ryan, Michelle Look, American Journal of Clinical Nutrition ObesityMetabolic SyndromeNutritionEnergy HomeostasisLifestyle Modification	2011	691
Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia Jonathan Davidson, Edna B. Foa, Jonathan D. Huppert, Archives of General Psychiatry	2004	411
Rational Design of a Combination Medication for the Treatment of Obesity Frank L. Greenway, M.J. Whitehouse, Maria Guttadauria, Obesity Bariatric SurgeryCombination MedicationPharmacotherapyObesity PreventionObesity	2008	342
Bupropion SR Enhances Weight Loss: A 48‐Week Double‐Blind, Placebo‐ Controlled Trial James W. Anderson, Frank L. Greenway, Ken Fujioka, Obesity Research	2002	316
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study Rajaa Nahra, Tao Wang, Kishore M. Gadde, Diabetes Care	2021	295
Zonisamide for Weight Loss in Obese Adults Kishore M. Gadde, Deborah M. Franciscy, Henry R. Wagner, JAMA	2003	276
Evaluation of phentermine and topiramate versus phentermine/topiramate extended‐release in obese adults Louis J. Aronne, Thomas A. Wadden, Craig A. Peterson, Obesity	2013	262
Serotonin-Related Gene Polymorphisms and Central Nervous System Serotonin Function Redford B. Williams, Douglas A. Marchuk, Kishore M. Gadde, Neuropsychopharmacology PsychiatrySerotonin-related Gene PolymorphismsHuman PolymorphismGenetic FactorNeuroscience	2002	260

Page 1